Larson Jennifer
SEC insider (Form 3/4/5 filer). CIK 0002149587. Chief Financial Officer at Bicara Therapeutics Inc. (BCAX). 1 reported Form 4/5 transaction since Sep 2024; latest on Aug 12, 2026. Located in BOSTON, MA.
Companies Larson Jennifer has filed insider reports for
- Bicara Therapeutics Inc. (BCAX): Officer, Chief Financial Officer
Larson Jennifer
CIK: 0002149587
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCAX
Bicara Therapeutics Inc.
Officer